Matthew Likens is the founder of GT Medical Technologies. GT Medical Technologies has raised $30M in total funding. Latest round: Series B.
Matthew Likens is the Chief Executive Officer of GT Medical Technologies, Inc., a company that provides GammaTile Therapy for the treatment of patients with operable brain tumors. The company's FDA-cleared GammaTile Surgically Targeted Radiation Therapy (STaRT) is designed for patients with various types of brain tumors. Since its full market release in March 2020, GammaTile has been adopted by over 90 hospitals across the United States.
Full founder directory · Investor directory · Company funding database · Fundraising library